APPLICATION OF VALIDATED RP-HPLC METHOD FOR SIMULTANEOUS DETERMINATION OF METAXALONE AND DICLOFENAC POTASSIUM IN PLASMA

DEVI RAMESH; MOHAMMAD HABIBUDDIN

doi:10.22159/ijcpr.2024v16i4.5039

Authors

DEVI RAMESH Government Polytechnic for Women, Warangal, Telangana-506002, India https://orcid.org/0000-0002-8838-0655
MOHAMMAD HABIBUDDIN Government Polytechnic for Women, Warangal, Telangana-506002, India

DOI:

https://doi.org/10.22159/ijcpr.2024v16i4.5039

Keywords:

Metaxalone, Diclofenac potassium, Liquid-liquid extraction, Method development, Matrix effect, Plasma, Recovery, Stability, Validation

Abstract

Objective: The present investigation demonstrates a simple, sensitive and accurate high-pressure liquid chromatographic (HPLC) method for simultaneous determination of metaxalone (MTX) and Diclofenac potassium (DIC) in plasma by using Valsartan (VSN) as internal standard.

Methods: The chromatographic separation was achieved within 10 min by using methanol: potassium dihydrogen phosphate buffer pH 4.5 adjusted with orthophosphoric acid (60:40) as mobile phase on Altima Grace Smart C-18 column (5μ; 250×4.6 mm) at flow rate of 1.0 ml/min with injection volume 25µl. The drug was extracted from plasma by liquid-liquid extraction using methanol as a solvent. The retention times of drugs (MTX and DIC) and internal standard were found to be 5.83, 9.65 and 11.79 min, respectively. This method was validated as per United States Food and Drug Administration (US-FDA) guidelines.

Results: The results of the validation parameters were found to be within the acceptance limits. The method was linear in the concentration range from 25-1000 ng/ml (r²= 0.9998) and the extraction recovery was found to be 77.06% for MTX and 78.37% for DIC. The lower limit of quantification was found to be 25ng/ml and the stability of recovered samples at different conditions were found to be more than 95% for both the drugs.

Conclusion: The developed method possesses good selectivity specificity, there was no interference found in the plasma blanks at retention times of MTX and DIC. We found good correlation between the peak area and concentration of the drug under prescribed conditions. Furthermore, the method can also be used to estimate the pharmacokinetic parameters of MTX and DIC simultaneously.

Downloads

Download data is not yet available.

References

Portenoy RK. Current pharmacotherapy of chronic pain. Journal of Pain and Symptom Management. 2000;19(1):16-20. doi: 10.1016/S0885-3924(99)00124-4.

Waldman HJ. Centrally acting skeletal muscle relaxants and associated drugs. Journal of Pain and Symptom Management. 1994;9(7):434-41. doi: 10.1016/0885-3924(94)90199-6.

Chou R, Peterson K, Helfand M. Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review. Journal of Pain and Symptom Management. 2004;28(2):140-75. doi: 10.1016/j.jpainsymman.2004.05.002.

Toth PP, Urtis J. Commonly used muscle relaxant therapies for acute low back pain: a review of carisoprodol, cyclobenzaprine hydrochloride, and metaxalone. Clin Ther. 2004;26(9):1355-67. doi: 10.1016/j.clinthera.2004.09.008, PMID 15530999.

Charlier C, Michaux C. Dual inhibition of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) as a new strategy to provide safer non-steroidal anti-inflammatory drugs. Eur J Med Chem. 2003;38(7-8):645-59. doi: 10.1016/s0223-5234(03)00115-6, PMID 12932896.

Kudo C, Kori M, Matsuzaki K, Yamai K, Nakajima A, Shibuya A. Diclofenac inhibits proliferation and differentiation of neural stem cells. Biochem Pharmacol. 2003;66(2):289-95. doi: 10.1016/s0006-2952(03)00235-1, PMID 12826271.

Panda SS. New stability-indicating RP-HPLC method for determination of diclofenac potassium and metaxalone from their combined dosage form. Sci Pharm. 2012;80(1):127-37. doi: 10.3797/scipharm.1109-16.

Nageswararao VSVS, Rao VV. Simultaneous estimation of diclofenac potassium and metaxalone in bulk and combined tablet dosage form using RP-HPLC method. Indian J Appl Res. 2018;8:57-9.

Bharathi DK, Shahana Begum, Laxmikanth Vaddepally, Tulja Rani G. Development and validation of new RP-HPLC method for simultaneous estimation of metaxalone and diclofenac potassium in tablet dosage form. Int J Res Pharm Chem. 2015;5:222-9.

Sahu P, Mathrusri AM, kumar SD. Development and validation of stability indicating RP-HPLC method for determination of metaxalone in bulk and its pharmaceutical formulations. E-Journal of Chemistry. 2011;8Suppl 1:S439-47.

Chintan RP, Ritu VK, Prachi VK, Harish AR, Nagund lVG. Spectrophotometric estimation of metaxalone and diclofenac potassium by multicomponent analytical method from tablet dosage form. J Anal Bioanal Tech. 2012;3:1000137.

US. Department of health and human sciences. Food Drug Administration, Guidance for industry, Bioanalytical method development and validation. U.S. Food Drug Administration, Center for Drug Evaluation and Research; 2001.

International Conference on Harmonization (ICH). Validation of analytical methods: methodology. ICH Q2 B; 1996.

Matuszewski BK, Constanzer ML, Chavez Eng CM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal Chem. 2003;75(13):3019-30. doi: 10.1021/ac020361s, PMID 12964746.

Hughes NC, Bajaj N, Fan J, Wong EY. Assessing the matrix effects of hemolyzed samples in bioanalysis. Bioanalysis. 2009;1(6):1057-66. doi: 10.4155/bio.09.91. PMID 21083074.

USP (The United States pharmacopoeia convention) 30-NF 25. Rockville MD. 2007;1005:1776.